Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www-thieme-connect-de.accesdistant.sorbonne-universite.fr/rss/thieme/en/10.1055-s-00000012.xml
Download PDF
Endoscopy 2010; 42(7): 546-556
DOI: 10.1055/s-0029-1244127
DOI: 10.1055/s-0029-1244127
Original article
© Georg Thieme Verlag KG Stuttgart · New York
Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE)
Further Information
Publication History
submitted 10 September 2009
accepted after revision 15 March 2010
Publication Date:
29 April 2010 (online)
Background and study aims: Lower gastrointestinal endoscopy (sigmoidoscopy and colonoscopy) and the fecal occult blood test (FOBT) are thought to impact on colorectal cancer incidence and mortality. We aimed to estimate prevalences and to investigate potential determinants of utilization of these procedures in the general population across Europe.
Methods: Data from the Survey of Health, Aging, and Retirement in Europe (SHARE) were used. Prevalences of lower gastrointestinal endoscopy and FOBT utilization among adults aged ≥ 50 years in 11 countries (Austria, Belgium, Denmark, France, Germany, Greece, Italy, The Netherlands, Spain, Sweden, and Switzerland) were estimated. Potential determinants of utilization of the tests were analyzed by multivariate logistic regression.
Results: Overall, 18 139 individuals were included. The proportion of respondents reporting lower gastrointestinal endoscopy and FOBT utilization within the previous 10 years ranged from 6.1 % (95 % confidence interval [CI] 4.7 – 6.9; Greece) to 25.1 % (95 %CI 22.1 – 27.2; France) and from 4.1 % (95 %CI 3.2 – 4.9; The Netherlands) to 61.1 % (95 %CI 58.6 – 63.6; Austria), respectively. Observed sex differences were highest in France and Germany; however results were only partly statistically significant. Country, age, education, income, marital status (FOBT only), location of main residence (FOBT only), smoking history, and self-perceived health status were statistically significant predictors of test utilization.
Conclusion: Prevalences of lower gastrointestinal endoscopy and FOBT utilization vary widely across European countries. They need to be considered in the interpretation of cross-national differences and time trends in colorectal cancer incidence and mortality, and in the design and evaluation of colorectal cancer screening programs.
References
- 1
Parkin D M, Bray F, Ferlay J, Pisani P.
Global Cancer Statistics, 2002.
CA Cancer J Clin.
2005;
55
74-108
MissingFormLabel
- 2 Ferlay J, Autier P, Boniol M. et al . Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007; 18 581-592
- 3 Hewitson P, Glasziou P, Irwig L. et al . Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007; CD001216
- 4 Newcomb P A, Norfleet R G, Storer B E. et al . Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992; 84 1572-1575
- 5 Müller A D, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med. 1995; 155 1741-1748
- 6 Baxter N N, Goldwasser M, Paszat L. et al . The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann Intern Med. 2009; 150 1-8
- 7 Kahi C J, Imperiale T F, Juliar B E, Rex D K. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009; 7 770-775
- 8 Arditi C, Peytremann-Bridevaux I, Burnand B. et al . Appropriateness of colonoscopy in Europe (EPAGE II) – screening for colorectal cancer. Endoscopy. 2009; 41 200-208
- 9 Levin B, Lieberman D A, McFarland B. et al . Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008; 134 1570-1595
- 10 U.S. Preventive Services Task Force . Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2008; 149 627-637
- 11 Sung J JY, Lau J Y, Young G P. et al . Asia Pacific consensus recommendations for colorectal cancer screening. Gut. 2008; 57 1166-1176
- 12 De Laet C, Neyt M, Vinck I. Health Technology Assessment, et al .
Colorectale Kankerscreening: wetenschappelijke stand van zaken en budgetimpact voor België. In: KCE reports. Brussels; Federaal Kenniscentrum voor de gezondheidszorg (KCE) 2006 - 13 Benson V S, Patnick J, Davies A K. et al . Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer. 2008; 122 1357-1367
- 14 Classen M, Lambert R. Colorectal cancer screening in Europe: a survey of the international digestive cancer alliance between November 2004 and March 2007. Z Gastroenterol. 2008; 46 23-24
- 15 Gutierrez-Ibarluzea I, Asua J, Latorre K. Policies of screening for colorectal cancer in European countries. Int J Technol Assess Health Care. 2008; 24 270-276
- 16 West N, Boustière C, Fischbach W. et al . Colorectal cancer screening in Europe: differences in approach; similar barriers to overcome. Int J Colorectal Dis. 2009; 24 731-740
- 17 Stock C, Haug U, Brenner H. Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trends. Gastrointest Endosc. 2010; 71 366-381
- 18 Klimont J, Kytir J, Leitner B. Austrian Health Survey 2006/2007 [Österreichische Gesundheitsbefragung 2006/2007 – Hauptergebnisse und methodische Dokumentation]. Vienna, Austria; Bundesministerium für Gesundheit, Familie und Jugend/Statistik Austria 2007
- 19 Haidinger G, Waldhoer T, Vutuc C. Self-reported colonoscopy screening in Austria. Eur J Cancer Prev. 2008; 17 354-357
- 20 Hoffmeister M, Chang-Claude J, Brenner H. Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk. Am J Epidemiol. 2007; 166 130-136
- 21 Sieverding M, Matterne U, Ciccarello L. Gender differences in FOBT use: evidence from a large German survey. Z Gastroenterol. 2008; 46 (suppl 1) S47-51
- 22 Wuppermann D, Wuppermann U, Riemann J F. Aktueller Wissensstand der Bevölkerung zur Darmkrebsvorsorge – eine Untersuchung der Stiftung LebensBlicke mit dem Institut für Demoskopie in Allensbach [Actual state of knowledge of the German population about the early detection of colorectal cancer – a study by ”the Stiftung LebensBlicke” in Cooperation with the Institute for Demoscopy in Allensbach]. Z Gastroenterol. 2009; 47 1132-1136
- 23 Kamposioras K, Mauri D, Golfinopoulos V. et al . Colorectal cancer screening coverage in Greece. PACMeR 02.01 study collaboration. Int J Colorectal Dis. 2007; 22 475-481
- 24 Börsch-Supan A, Hank K, Jürges H. A new comprehensive and international view on ageing: introducing the ’Survey of Health, Ageing and Retirement in Europe’. Eur J Ageing. 2005; 2 245-253
- 25 Börsch-Supan A, Jürges H, eds The Survey of Health, Aging, and Retirement in Europe – Methodology. Mannheim, Germany; Mannheim Research Institute for the Economics of Aging (MEA) 2005 Available at http://www.share-project.org/ [Accessed: 25 January 2010]
MissingFormLabel
- 26 Börsch-Supan A, Brugiavini A, Jürges H et al., eds Health, Ageing and Retirement in Europe. First results from the Survey of Health,
Ageing and Retirement in Europe. Mannheim, Germany; Mannheim Research Institute for the Economics of Aging (MEA) 2005 Available at: http://www.share-project.org/ [Accessed: 25 January 2010]
MissingFormLabel
- 27 Börsch-Supan A, Kemperman M.
The SHARE development process. In: Börsch-Supan A, Jürges H, eds The Survey of Health, Aging, and Retirement in Europe – Methodology. Mannheim, Germany; Mannheim Research Institute for the Economics of Aging (MEA) 2005 - 28 Brugiavini A, Croda E, Paccagnella O. et al .
Generated income variables in SHARE release 1. In: Börsch-Supan A, Jürges H, eds The Survey of Health, Aging, and Retirement in Europe – Methodology. Mannheim, Germany; Mannheim Research Institute for the Economics of Aging (MEA) 2005 - 29 Breen N, Wagener D K, Brown M. et al . Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001; 93 1704-1713
- 30 Subramanian S, Amonkar M M, Hunt T L. Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2005; 14 409-416
- 31 Ata A, Elzey J D, Insaf T Z. et al . Colorectal cancer prevention: adherence patterns and correlates of tests done for screening purposes within United States populations. Cancer Detect Prev. 2006; 30 134-143
- 32 Meissner H I, Breen N, Klabunde C N, Vernon S W. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006; 15 389-394
- 33 McQueen A, Vernon S W, Meissner H I. et al . Are there gender differences in colorectal cancer test use prevalence and correlates?. Cancer Epidemiol Biomarkers Prev. 2006; 15 782-791
- 34 Centers for Disease Control and Prevention (CDC) . Use of colorectal cancer tests – United States, 2002, 2004, and 2006. MMWR – Morb Mortal Wkly Rep. 2008; 57 253-258
- 35 Shapiro J A, Seeff L C, Thompson T D. et al . Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008; 17 1623-1630
- 36 Beydoun H, Beydoun M. Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control. 2008; 19 339-359
- 37 Cokkinides V E, Chao A, Smith R A. et al . Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med. 2003; 36 85-91
- 38 Pollack L A, Blackman D K, Wilson K M. et al . Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations. Prev Chronic Dis. 2006; 3 A50
- 39 Ioannou G N, Chapko M K, Dominitz J A. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003; 98 2082-2091
- 40 Thompson B, Coronado G, Neuhouser M, Chen L. Colorectal carcinoma screening among Hispanics and non-Hispanic whites in a rural setting. Cancer. 2005; 103 2491-2498
- 41 Honda K. Factors associated with colorectal cancer screening among the US urban Japanese population. Am J Public Health. 2004; 94 815-822
- 42 Kahi C J, Rex D K, Imperiale T F. Screening, surveillance, and primary prevention for colorectal cancer: a review of the recent literature. Gastroenterology. 2008; 135 380-399
- 43 Carlos R C, Underwood 3rd W, Fendrick A M, Bernstein S J. Behavioral associations between prostate and colon cancer screening. J Am Coll Surg. 2005; 200 216-223
- 44 Pox C, Schmiegel W, Classen M. Current status of screening colonoscopy in Europe and in the United States. Endoscopy. 2007; 39 168-173
- 45 International Cancer Screening Network (ICSN) .Inventory of colorectal cancer screening activities in ICSN countries, May 2008. http://appliedresearch.cancer.gov/icsn/colorectal/screening.html [Accessed: 15 June 2009]
- 46 Adler M, Van Laethem J L, Franchimont D. et al . [Organized colorectal screening in French Community of Belgium and polyp surveillance]. Rev Med Brux. 2009; 30 253-260
- 47 Vrangbaek K, Nielsen M. Colorectal cancer care in Denmark: status and dilemmas. Eur J Health Econ. 2010; 10 5-13
- 48 Goulard H, Boussac-Zarebska M, Ancelle-Park R, Bloch J. French colorectal cancer screening pilot programme: results of the first round. J Med Screen. 2008; 15 143-148
- 49 Goulard H, Boussac-Zarebska M, Ancelle-Park R, Bloch J. Évaluation épidémiologique du dépistage du cancer du côlon et du rectum. Premières campagnes du programme pilote français [Epidemiological evaluation of the French colorectal cancer screening pilot programme: results of the first round]. Saint-Maurice cedex Institut de veille sanitaire 2007 http://www.invs.sante.fr/publications/2007/cancer_colon_rectum/cancer_colon_rectum.pdf
- 50 Ponchon T. Mass screening for colorectal cancer: the French program. Endoscopy. 2007; 39 256
- 51 Chevreul K. Colorectal cancer in France. Eur J Health Econ. 2010; 10 15-20
- 52 Pox C, Schmiegel W. Colorectal screening in Germany. Z Gastroenterol. 2008; 46 31-32
- 53 Dimitrakaki C A, Boulamatsis D B, Mariolis A C. et al . Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey. Eur J Cancer Prev. 2009; 18 248-257
- 54 Geitona M, Kanavos P. Colocteral cancer management and prevention policies in Greece. Eur J Health Econ. 2010; 10 S27-S33
- 55 Masseria C. Colorectal cancer in Italy: a review of current national and regional practice on screening and treatment. Eur J Health Econ. 2010; 10 41-49
- 56 Zorzi M, Fedato C, Naldoni C. et al . Screening for colorectal cancer in Italy: 2007 survey. Epidemiol Prev. 2009; 33 57-74
- 57 Schurer W. The status of colorectal cancer care in the Netherlands: past, present and future. Eur J Health Econ. 2010; 10 51-56
- 58 Lopez-Bastida J, Bellas-Beceiro B, Quintero-Carrión E. The challenge of colorectal cancer prevention in Spain. Eur J Health Econ. 2010; 10 75-83
- 59 Hakama M, Hoff G, Kronborg O, Pahlman L. Screening for colorectal cancer. Acta Oncologica. 2005; 44 425-439
- 60 Krebsliga Schweiz .Darmkrebs nie! Aber wie? Symposiumsbericht der Krebsliga Schweiz. 2007 Sept. 13. Bern; Krebsliga Schweiz 2008 Available at: http://www.colon-cancer.ch [Accessed: 25 Januar 2010]
- 61 Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, IARC CancerBase No. 5. version 2.0. Lyon; IARC Press 2004
- 62 Black R J, Bray F, Ferlay J, Parkin D M. Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990. Eur J Cancer. 1997; 33 1075-1107
- 63 Horner M J, Ries L AG, Krapcho M. et al .SEER Cancer Statistics Review, 1975 – 2006, National Cancer Institute. 2009 Bethesda, MD; http://seer.cancer.gov/csr/1975_2006 /, based on November 2008 SEER data submission, posted to the SEER web site
- 64 Baier M, Calonge N, Cutter G. et al . Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2000; 9 229-232
- 65 Hall H I, Van Den Eeden S K, Tolsma D D. et al . Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med. 2004; 39 27-35
H. BrennerMD, MPH
Division of Clinical Epidemiology and Aging Research
German Cancer Research Center (DKFZ)
Bergheimer Strasse 20
69115 Heidelberg
Germany
Fax: +49-6221-548141
Email: h.brenner@dkfz.de